Abacavir and Diabetes
- 11 January 2001
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 344 (2) , 142-144
- https://doi.org/10.1056/nejm200101113440216
Abstract
We describe a patient infected with the human immunodeficiency virus (HIV) in whom diabetes mellitus developed in association with treatment with abacavir, a new nucleoside reverse-transcriptase inhibitor.Keywords
This publication has 6 references indexed in Scilit:
- Beta-cell mitochondria in the regulation of insulin secretion: a new culprit in Type II diabetesDiabetologia, 2000
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophyThe Lancet, 1999
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- A Review of Protease Inhibitor‐Induced HyperglycemiaPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999
- Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesisAntimicrobial Agents and Chemotherapy, 1994
- Hyperosmolar Nonketotic Diabetic Syndrome Following Treatment of Human Immunodeficiency Virus Infection With DidanosineDiabetes Care, 1994